Join the 'Dermal Filler' group to help and get support from people like you.
Dermal Filler News
Posted 1 Oct 2015 by Drugs.com
DUBLIN, Oct. 1, 2015 /PRNewswire/ – Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvederm Ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. Juvederm Ultra XC instantly adds fullness to the lips and is the ...
FDA Medwatch Alert: Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication - Risk of Serious Patient Injury
Posted 1 Jun 2015 by Drugs.com
[Posted 05/28/2015] ISSUE: The FDA has reviewed information that suggests unintentional injection of soft tissue fillers into blood vessels in the face can result in rare, but serious side effects. Unintentional injection can block blood vessels and restrict blood supply to tissues. Sometimes this can result in embolization. This means the filler material has traveled to other parts of the ...
Posted 14 Aug 2014 by Drugs.com
THURSDAY, Aug. 14, 2014 – Injectable dermal fillers are widely used by people seeking to smooth out wrinkles, but it's important to know the risks of these products before using them, a U.S. government expert says. Dermal fillers use a variety of materials to treat facial wrinkles. Most of these products are temporary and last for about six months or more. Only one permanent wrinkle filler is ...
FDA Medwatch Alert: Expression Injectable by Enhancement Medical: FDA Safety Communication - Adverse Events Associated with Unapproved Use As a Dermal Filler
Posted 7 Aug 2014 by Drugs.com
ISSUE: The FDA has become aware of adverse events associated with the unapproved use of the Expression product, hyaluronic acid that is packaged in a syringe, as a dermal filler. Events have included swelling, tenderness, firmness, lumps, bumps, bruising, pain, redness, discoloration, itching, and the development of hard nodules. BACKGROUND: Expression is listed with the FDA as an intranasal ...
Merz Aesthetics Announces FDA Approval of Belotero Balance Dermal Filler for the Correction of Moderate-to-Severe Facial Wrinkles and Folds
Posted 17 Nov 2011 by Drugs.com
SAN MATEO, Calif., November 16, 2011 – Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Belotero Balance for the correction of moderate-to-severe facial wrinkles and folds. Belotero Balance filler is a hyaluronic acid-based cohesive gel dermal filler designed to deliver natural-looking results with little recovery time. Belotero filler ...
Related Condition Support Groups
Related Drug Support Groups
Juvederm, Bellafill, Restylane, Radiesse, Perlane, ArteFill, Belotero Balance, Captique, Restylane Refyne, view more... Restylane Defyne, Juvederm XC, Evolence, Restylane Lyft, Restylane Silk, Hylaform Plus